Skip to main content

Table 3 Basic data

From: Classification of chronic cough by systematic treatment cascade trial starting with beta agonist

 

BA

CVA

NHBRC

AC

SBS

GERD

 

(n = 19)

(n = 47)

(n = 30)

(n = 17)

(n = 5)

(n = 12)

Duration (days)

421 (898)

195 (428)

491 (1194)

654 (1406)

399 (396)

97 (39)

IgE ( IU/ml)

1181 (3349)

291 (583)

262 (542)

255 (383)

127 (198)

139 (168)

PND (%)

26

32

18

29

100*

17

PC20 (mg/ml)

4.347 (5.820)*

4.149 (2.944)*

>20

>20

>20

>20

%VC (%)

113 (18)

106 (15)

112 (13)

118 (17)

105 (20)

115 (13)

%FEV1/FVC (%)

72 (11)*

81 (11)

83 (7)

83 (7)

75 (8)

82 (6)

  1. Data are means (SD). Patients with a single diagnosis were selected for comparison. IgE, serum IgE level; PND (%), percentage of patients with postnasal drip; PC20, methacholine concentration which induces a 20% decrease in the forced expiratory volume in one second (FEV1); %VC, percentage of predicted value of vital capacity; %FEV1/FVC; FEV1/FVC ratio expressed by percentage. * p < 0.05.